Roche’s fenebrutinib shows positive results in Phase 2 FENopta study

By NS Healthcare Staff Writer

18 May 23

In the Phase 2 study, which met its primary and secondary endpoints, Roche’s investigational, potent and highly selective…

PharmaceuticalsClinical trials

Investment consortium to acquire Syneos Health for more than $7bn

By NS Healthcare Staff Writer

10 May 23

The consortium comprising Elliott Investment Management, an affiliate of Elliott Associates, along with healthcare investment firm Patient Square…

PharmaceuticalsClinical trials

ESSA, Janssen to evaluate combination therapies to treat prostate cancer

By NS Healthcare Staff Writer

13 Apr 23

As part of the clinical trial support agreement, ESSA will sponsor and conduct a Phase 1 trial of…

PharmaceuticalsClinical trials

KinoPharma and IWAKI SEIYAKU initiate Phase 2 study of cutaneous warts drug

By NS Healthcare Staff Writer

10 Apr 23

The two companies decided to conduct a Phase 2 clinical trial of the drug after confirming the safety…

PharmaceuticalsClinical trials

Pfizer, Valneva partly discontinue Lyme disease vaccine trial in US

By NS Healthcare Staff Writer

20 Feb 23

The discontinuation of US participants is due to violation of Good Clinical Practice (GCP) at certain clinical trial…

PharmaceuticalsClinical trials

Fujifilm begins new Phase 3 study to evaluate stem cell therapy candidate

By NS Healthcare Staff Writer

15 Feb 23

The Phase 3 clinical trial, to be conducted by Fujifilm’s subsidiary Fujifilm Toyama Chemical, and the Foundation for…

PharmaceuticalsClinical trials

Pfizer’s Haemophilia B gene therapy meets primary endpoint in Phase 3 study

By NS Healthcare Staff Writer

02 Jan 23

The Phase 3 study has met its primary endpoint of non-inferiority and superiority in the annualised bleeding rate…

PharmaceuticalsClinical trials

Novartis’ Pluvicto offers survival benefit in PSMA-positive mCRPC, says study

By NS Healthcare Staff Writer

06 Dec 22

The Phase 3 trial has met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA-positive mCRPC who…

PharmaceuticalsClinical trials

Hyundai Bioscience to launch clinical trial of Polytaxel in pancreatic cancer

By NS Healthcare Staff Writer

28 Nov 22

The South Korean biotech firm claimed that the anticancer therapy candidate could complete chemotherapy with two doses in…

Clinical trialsPharmaceuticals

Investigational mRNA vaccine shows promise against all 20 flu strains

By NS Healthcare Staff Writer

25 Nov 22

The two-dose vaccine, which leverages the same mRNA technology used in the Covid-19 vaccines developed by Pfizer and…

PharmaceuticalsClinical trials